EXPERIENCE OF USING LAKOSAMID IN VARIOUS FORMS OF EPILEPSY (The results of observational study in city outpatient health care chain of Moscow)
Abstract
This paper presents experience of using Vimpat in outpatient health care chain of Moscow. In the observational study were attended 49 patients with difficult for treatment focal forms of epilepsy (cryptogenic and symptomatic forms). Vimpat used in complex therapy in the mean effective dose of 300-400 mg per day. As a result, the data on a cohort of Russian patients showed that Vimpat demonstrate a sufficiently high clinical efficacy (55%, p<0.01) and appropriate for use in patients with difficult for treatment forms of epilepsy in complex therapy when the previous treatment was ineffective.
About the Authors
I. Yu. Artyomova
City outpatient clinics of Moscow
Russian Federation
Russian Federation
O. L. Badalyan
City outpatient clinics of Moscow
Russian Federation
Russian Federation
M. A. Bogomazova
City outpatient clinics of Moscow
Russian Federation
Russian Federation
I. I. Zhuravleva
City outpatient clinics of Moscow
Russian Federation
Russian Federation
A. M. Ismailov
City outpatient clinics of Moscow
Russian Federation
Russian Federation
E. G. Komelkova
City outpatient clinics of Moscow
Russian Federation
Russian Federation
L. N. Lesinker
City outpatient clinics of Moscow
Russian Federation
Russian Federation
O. V. Otcheskaya
City outpatient clinics of Moscow
Russian Federation
Russian Federation
S. V. Petrov
City outpatient clinics of Moscow
Russian Federation
Russian Federation
Yu. V. Solomatin
City outpatient clinics of Moscow
Russian Federation
Russian Federation
A. M. Teplysheva
City outpatient clinics of Moscow
Russian Federation
Russian Federation
T. N. Vdovichenko
City outpatient clinics of Moscow
Russian Federation
Russian Federation
E. A. Khromykh
City outpatient clinics of Moscow
Russian Federation
Russian Federation
A. S. Chukanova
City outpatient clinics of Moscow
Russian Federation
Russian Federation
A. V. Lebedeva
Department of neurology and neurosurgery, The Russian state medical university (RSMU)
Russian Federation
Russian Federation
S. G. Burd
Department of neurology and neurosurgery, The Russian state medical university (RSMU)
Russian Federation
Russian Federation
A. N. Boyko
Department of neurology and neurosurgery, The Russian state medical university (RSMU)
Russian Federation
Russian Federation
References
1. Ben-Menachem E, Biton V, Jatuzis D, AbouKhalil B, Doty P, Rudd G D. (2007) Epilepsia. 2007 Jul;48(7):1308-17.
2. Beydoun A, D'Souza J, Hebert D, Doty P. (2009) Expert Rev Neurother. 2009 Jan; 9(1): 33-42.
3. Beyreuther B K, Freitag J, Heers C, Krebsfänger N, Scharfenecker U, Stöhr T. Lacosamide: A review of preclinical properties. CNS Drug Reviews. 2007; 13(1): 21-42
4. Chung S, Sperling M R, Biton V, Krauss G, Hebert D, Rudd G D, Doty P; SP 754 Study Group. (2010) Epilepsia. 2010 Jun; 51(6): 958-67
5. Curia G, Biagini G, Perucca E, Avoli M. (2009) CNS Drugs. 2009; 23(7): 555-68
6. Errington AC, Stohr T, Heers C, Lees G. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol. 2008 Jan; 73(1): 157-69
7. Harris J A, Murphy J A. (2009), Ann Pharmacother. 2009 Nov; 43(11): 1809-17
8. Isojarvi J, Hebert D, Doty P et al. Evaluation of lacosamide efficacy and safety as adjunctive therapy in patients receiving traditional sodium channel blocking AEDs. Presented at the 9th European Congress on Epileptology, Rhodes, Greece. 27 June-1 July 2010
9. Kwan M.D., Brodie M.J. Early identification of refractory epilepsy. NEJM.-2000.-V.342. -№5.-P.314-319.
10. Niespodziany I, Leclère N, Vandenplas C, Foerch P and Wolff C. Comparative study of
11. lacosamide with other sodium channel blocking antiepileptic drugs on sodium current slow inactivation. Presented at the 9th European Congress on Epileptology, Rhodes, Greece. 27 June-1 July 2010
12. Patyar S, Medhi B. (2010) Neurosciences (Riyadh). 2010 Jan; 15(1): 3-6.
13. Sake J-K, Hebert D, Doty P et al. Lacosamide efficacy and safety in patients taking AEDs that act on non-sodium channel targets. Presented at the 9th European Congress on Epileptology, Rhodes, Greece. 27 June-1 July 2010.
Review
For citations:
Artyomova I.Yu., Badalyan O.L., Bogomazova M.A., Zhuravleva I.I., Ismailov A.M., Komelkova E.G., Lesinker L.N., Otcheskaya O.V., Petrov S.V., Solomatin Yu.V., Teplysheva A.M., Vdovichenko T.N., Khromykh E.A., Chukanova A.S., Lebedeva A.V., Burd S.G., Boyko A.N. EXPERIENCE OF USING LAKOSAMID IN VARIOUS FORMS OF EPILEPSY (The results of observational study in city outpatient health care chain of Moscow). Epilepsy and paroxysmal conditions. 2011;3(3):15-20. (In Russ.)
Views: 417
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
